Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Randomized Controlled Trial of Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients

NCT04500626 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT04500626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04500626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Randomized Controlled Trial of Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients
Lead sponsor
Ottawa Hospital Research Institute
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 15, 2021
Completion date
August 31, 2022
Enrollment
234 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19